Workflow
福森药业(01652)股东将股票存入银河证券香港 存仓市值3806.88万港元
FUSEN PHARMFUSEN PHARM(HK:01652) 智通财经网·2025-09-22 00:16

Group 1 - The core point of the article is that Fosen Pharmaceuticals has received approval from the National Medical Products Administration of China for its drug Metformin and Ertugliflozin Tablets, which is intended for the treatment of type 2 diabetes in adults [1] - On September 19, shareholders of Fosen Pharmaceuticals deposited shares worth HKD 38.0688 million into Galaxy Securities Hong Kong, representing 5% of the total shareholding [1]